Hepatitis C Virus Infection
101
6
7
71
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
53 trials with published results (52%)
Research Maturity
71 completed trials (70% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
5.0%
5 terminated out of 101 trials
93.4%
+6.9% vs benchmark
35%
35 trials in Phase 3/4
75%
53 of 71 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 71 completed trials
Clinical Trials (101)
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Digital Community to Improve Health in Rural Areas
Hepatitis C Tracker Study
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy
Early Detection of HCV in Injection Drug Users
Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
Screening, Treatment, and Eradication of Hep C
Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men
Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia
Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)
Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C
Implementing HCV Treatment for High-risk Populations in Austin, Texas
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women
Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study
Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects